Hanseatic Management Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Hanseatic Management Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-524	Closed	-$293K	–	204
2020 Q3	$293K	Sell	524 -2,288	-81%	-$1.39M	0.66%	45
2020 Q2	$1.75M	Buy	2,812 +529	+23%	+$300K	1.48%	12
2020 Q1	$1.11M	Buy	+2,283	New	+$942K	1.19%	15
2019 Q2	–	Sell	-1,412	Closed	-$580K	–	262
2019 Q1	$580K	Buy	+1,412	New	+$581K	0.6%	72
2016 Q1	–	Sell	-490	Closed	-$266K	–	303
2015 Q4	$266K	Sell	490 -4,190	-90%	-$2.27M	0.09%	159
2015 Q3	$2.18M	Buy	4,680 +730	+18%	+$392K	0.68%	47
2015 Q2	$2.02M	Sell	3,950 -120	-3%	-$58.6K	0.89%	29
2015 Q1	$1.84M	Sell	4,070 -610	-13%	-$259K	0.98%	30
2014 Q4	$1.92M	Hold	4,680	–	–	0.98%	29
2014 Q3	$1.69M	Buy	+4,680	New	+$1.57M	0.9%	32
2013 Q4	–	Sell	-102	Closed	-$32K	–	299
2013 Q3	$32K	Sell	102 -7,570	-99%	-$1.99M	0.02%	145
2013 Q2	$1.73M	Buy	+7,672	New	+$1.79M	1.04%	31

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Hanseatic Management Services's REGN Position: Q4 2020 in Review

Hanseatic Management Services sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 524 shares — an estimated $293K sold.

Hanseatic Management Services first reported a position in REGN in Q2 2013 and held it in 12 quarters. The position peaked at $2.18M in Q3 2015. 904 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

Hanseatic Management Services reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Hanseatic Management Services sold 524 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $293K.
Hanseatic Management Services first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 12 quarters.
Hanseatic Management Services's Regeneron Pharmaceuticals position peaked at $2.18M in Q3 2015.
904 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on Hanseatic Management Services's 13F filing for Q4 2020, filed 29 Jan 2021.